SCHEMBL30990442

SCHEMBL30990442

Nc1ncnc2c1c(-c1noc(C3CC3)c1I)nn2C1CC(C(=O)O)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 10/20 0.49
▸ SRC P12931 4/20 0.41
▸ KDR P35968 3/20 0.41
▸ LCK P06239 3/20 0.41
▸ CDC7 O00311 1/20 0.41
▸ PLK4 O00444 1/20 0.41
▸ DYRK3 O43781 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ NTRK1 P04629 1/20 0.41
▸ INSR P06213 1/20 0.41
▸ FYN P06241 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ ROS1 P08922 1/20 0.41
▸ FER P16591 1/20 0.41
▸ PRKACA P17612 1/20 0.41
▸ RPS6KB1 P23443 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ MARK3 P27448 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30990419 0.89 RET (0.49) RETSRCKDREGFRBTK
SCHEMBL31640083 0.87 RET (0.57) RETSRCKDRLCKCDC7
SCHEMBL30990408 0.87 RET (0.47) RETSRCKDRLCKCDC7
SCHEMBL31640064 0.85 RET (0.62) RETSRCKDRLCKEGFR
SCHEMBL30990436 0.83 RET (0.54) RETSRCKDRLCKEGFR
SCHEMBL30990479 0.81 RET (0.71) RETKDRRPS6KB1FLT4HCK
SCHEMBL31640292 0.77 RET (0.58) RETSRCKDRLCKPLK4
SCHEMBL21179092 0.75 RET (0.69) RETSRCKDRRPS6KB1FLT4
SCHEMBL31639447 0.74 RET (0.57) RETKDRRPS6KB1FLT4HCK
SCHEMBL31640565 0.74 RET (0.53) RETSRCKDRLCKCDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665720-A2 ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE Bristol-Myers Squibb Company (US) 2025-12-24 — — EP disclosed
WO-2024173832-A2 ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE BRISTOL-MYERS SQUIBB COMPANY (US) 2024-08-22 — — WO disclosed
Send feedback